UNSPSC 51372201: Dextromoramide

This classification denotes an opioid receptor agonist with the molecular formula C25H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9S4S6CIY83, chemically known as pyrrolidine, 1-(3-methyl-4-(4-morpholinyl)-1-oxo-2,2-diphenylbutyl)-, (s)- but generally known as dextromoramide, which bears US NIH Compound Identifier 9648. European Medicines Agency schedules Dextromoramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07052MIG.

UNSPSC 51372201 Dextromoramide is a Commodity code identifying a controlled opioid pharmaceutical product, though recent state and local procurement activity under this code shows limited relevance to the code's nominal scope. The only recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS posted June 30, 2026—solicits naloxone and drug deactivation systems rather than dextromoramide itself, indicating a potential mismatch between the code assignment and the actual procurement category. State and local governments appear to use this code infrequently or inconsistently for opioid-related purchases; the available record does not establish a clear pattern of issuing-body types or purchasing practices under the code's intended scope.

Seminole County's naloxone procurement represents the only documented recent activity. The county issued an IFB seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. The contract carried a two-year initial term with a one-year renewal option, included E-Verify and drug-free workplace compliance requirements, and was potentially funded through FEMA. The code shows no broader geographic activity or repeat issuing bodies in the recent-opportunities record.